Previous Close | 0.0200 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0200 |
Strike | 19.00 |
Expire Date | 2024-10-11 |
Day's Range | 0.0200 - 0.0200 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
Pfizer Stock Jumps 3% Following Starboard Value Investment
LONDON (Reuters) -Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents relating to messenger RNA (mRNA) technology, which underpins Pfizer and BioNTech's COVID-19 vaccine.